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Prognostic Value of Diagnostic 
Sonography in Patients With 
Plantar Fasciitis
lantar fasciitis is one of the most common causes of foot pain
in adults. The lifetime risk of developing plantar heel pain is
10%, and more than 1 million outpatient visits annually can
be attributed to the condition.1 Plantar fasciitis is usually diagnosed
clinically by the presentation of pain in the plantar heel that is worse
when initiating walking. Local point tenderness is also frequently
present when palpating along the fascia and medial calcaneal tubercle.
However, radiographic studies are sometimes required to establish
the diagnosis when there is uncertainty and in patients presenting
with persistent plantar heel pain.
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ORIGINAL RESEARCH
Objectives—The primary objective of this study was to determine whether the sono-
graphic appearance of the plantar fascia is predictive of the treatment (ie, pain) response
in patients receiving supportive therapy for proximal plantar fasciitis. This study was a
secondary analysis of data obtained from a randomized controlled trial of ambulatory
adults, which examined the efficacy of 3 different foot supports for plantar fasciitis. 
Methods—Participants underwent diagnostic sonographic examinations of their heel
at baseline and again at 3 months by a single experienced foot and ankle surgeon.
Quantitative (eg, thickness) and qualitative (eg, biconvexity) characteristics of the
fascia were recorded according to a standard protocol. Logistic regression models
were used to identify predictors of the pain response.
Results—Seventy patients completed a baseline evaluation, and 63 patients completed a
3-month follow-up assessment. The pain response was not associated with the type of
foot support (P > .05). The only significant indicator of an unfavorable response in the uni-
variate and multivariate analyses was biconvexity of the plantar fascia on sonography at
presentation (multivariate odds ratio, 4.76 [95% confidence interval, 1.16–19.5; P = .030).
Furthermore, changes in self-reported pain over the 3-month study period were not
accompanied by alterations in plantar fascia thickness over this time (r = .056; P = .671). 
Conclusions—We conclude that patients who present with biconvexity of the plantar
fascia may be less responsive to tier 1 treatment regimens that center around mechan-
ical support of the plantar fascia. Furthermore, follow-up measurements of the fascia in
this population should not weigh heavily in decisions such as return to play. 
Key Words—biconvexity; heel pain; musculoskeletal ultrasound; plantar fascia;
predictors; sonography
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In patients suspected of having plantar fasciitis, the pri-
mary indication for imaging is to rule out other competing
disorders that can also cause heel pain, such as calcaneal
stress fractures, benign bone tumors, and infracalcaneal
bursitis. However, diagnostic sonography also provides the
examiner with additional insight, such as plantar fascia
thickness, morphologic characteristics of the fascia, echo
texture of the fascia, and whether perifascial fluid is present.2,3
Musculoskeletal sonography has grown in popularity during
the past 2 decades, primarily because it offers the potential
for noninvasive, cost-effective, point-of-care testing.4–6
Although sonography is now generally accepted as an
effective diagnostic tool for plantar fasciitis, it is unclear
whether the sonographic appearance of the fascia can
provide any further insight into disease severity and, most
importantly, disease prognosis. Our study therefore had 2
aims: (1) to determine whether sonographic characteristics
of the plantar fascia were associated with pain magnitude
and disability in patients with proximal plantar fasciitis; and
(2) to determine whether certain sonographic character-
istics of the plantar fascia were predictive of the short-term
treatment response in patients treated primarily with sup-
portive (tier 1) therapies. 
Materials and Methods
Participants and Procedures
This study represents a secondary analysis of data obtained
from a prospective, double-blind randomized clinical trial
that evaluated the efficacy of 3 different mechanical supports
for treatment of proximal plantar fasciitis (ClinicalTrials.gov
identifier NCT00765843).7 In this study, ambulatory
adult men and women with heel pain for less than 12
months were recruited from 2 high-volume foot and ankle
specialty clinics in the greater Chicago area. Participants
were randomly assigned to 1 of 3 treatment groups: cus-
tom foot orthoses, prefabricated over-the-counter insoles,
or sham insoles. Participants also received athletic shoes
and instructions for daily icing and were asked to perform
daily calf stretches. Compliance was evaluated by a self-
reported questionnaire at 3 months.
Eligible patients had to present with pain at the plantar
fascial attachment to the calcaneal tubercle, have poststatic
dyskinesia, and have a diagnosis of proximally based
plantar fasciitis. Furthermore, included patients had 
to have symptoms for no greater than 1 year and could not
have had heel spur injections in the prior 6 months.
Patients who were unable to wear supportive closed-toed
shoes and patients using gait-assistive devices were excluded
from the study, as were patients with other proximal
musculoskeletal disorders such as hip or knee arthritis,
sciatica, and substantial limb length discrepancy. The history,
foot radiography, and diagnostic sonography were used to
rule out other etiologies of heel pain, including arthritis, a
heel spur, or a stress fracture. The study received approval
from the Institutional Review Boards at Rosalind Franklin
University of Medicine and Science and Advocate Health
Care. All participants were treated in accordance with the
Declaration of Helsinki.
Outcome measures examined at baseline, 1 month, and
3 months included an ordinal 10-point pain scale for first-
step pain and end-of-day pain. The revised Foot Function
Index (FFI-R)8,9 and 36-Item Short-Form Health Survey
questionnaire10 were also used to evaluate the level of pain
and disability. Participants received a diagnostic sonographic
examination of their plantar fascia at baseline and again at
a 3-month follow-up. Examinations were performed by a
single foot and ankle surgeon (A.E.F.) with greater than 5
years of experience in performing dedicated foot and ankle
sonographic examinations. The standardized examination
consisted of evaluation of the study and nonstudy heels by an
8.0-MHz linear array transducer (Aquila LA 30C/40 MM;
Biosound Esaote, Indianapolis, IN). Evaluation was made
with the patient supine, in full knee extension and 90° of
ankle dorsiflexion. The thickness of the plantar fascia was
measured at 2 points on a longitudinal view of the heel.
The first measurement was taken from the anterior edge
of the inferior calcaneal border to the inferior border of the
sonographic abnormality and the second from a point 1 cm
distal to that location.6,11 Measurements were taken from
the region of maximal thickness, which usually corresponded
to the medial plantar fascial band or medial portion of the
central plantar fascial band. Qualitative changes, such as low
echogenicity, a biconvex shape, perifascial fluid, and subcu-
taneous edema, were also recorded (yes/no). Biconvexity
was defined simply as a circular appearance within the fas-
cia occurring at the infracalcaneal origin (Figure 1).
Statistical Analysis
To analyze the first study aim, the relationships between
continuous sonographic characteristics and pain level
(including pain [morning, evening, and the average of
morning and evening values] and the pain subscale of the
FFI-R), and disability (total FFI-R score and the remaining
4 subscales) were graphically explored by using scatterplots.
Assessment of a linear correlation was determined by the
Pearson correlation coefficient (r). Dichotomous sono-
graphic characteristics were tested for their association
with foot pain and function by using an independent t test
and simple regression.
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For the second study aim, patient demographics
(body mass index [BMI], age, sex, etc) and baseline char-
acteristics (laterality of heel pain, type of mechanical con-
trol, duration of heel pain, magnitude of heel pain, etc)
were stratified by the pain response: favorable versus unfa-
vorable. A favorable response was considered as a 50% or
greater reduction in self-reported pain by the 3-month fol-
low-up (using an average of the pain scores for morning
and evening pain levels). Missing values were imputed with
mean or median values for the study population. Baseline
sonographic characteristics were examined for their asso-
ciation with the treatment response by using univariate
logistic regression, with the strength of the association
reported as odds ratios and 95% confidence intervals.
Potentially important sonographic, demographic, and
other baseline characteristics (P < .25) were then entered
into a multivariable logistic regression analysis to deter-
mine the best predictor model for the treatment response.
The final multivariate model was determined by using
stepwise logistic regression with P < .05 as the criterion
for model entry and P ≥ .05 for removal. Age and BMI
were automatically retained in the final model because of
their clinical relevance. The final model was tested for good-
ness of fit by using the Hosmer-Lemeshow test. Statistical
analyses were conducted with SAS version 9.2 software
(SAS Institute, Inc, Cary, NC; and Microsoft Corporation,
Redmond, WA). All tests of significance were 2 tailed, with
P < .05 considered significant. 
Results
There were 2 missing values: 1 for height and another for
the self-reported time spent standing per day. These values
were imputed with the mean value for the study population.
J Ultrasound Med 2015; 34:1729–1735 1731
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Figure 1. a, Longitudinal sonogram from a patient with plantar fasciitis showing diffuse thickening and hypoechogenicity of the plantar fascia (pF)
at the infracalcaneal origin (calc), without biconvexity. b, The box indicates that the superior and inferior plantar fascial borders are relatively parallel
to one another. c and d, Longitudinal sonograms from a patient with plantar fasciitis showing focal thickening and rounding of the plantar fascia at
the infracalcaneal origin, consistent with biconvexity. This feature was originally described by Akfirat et al.6
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There were 70 patients who had completed baseline evalu-
ation and testing for inclusion in this analysis and 63 patients
who had completed a 3-month follow-up assessment that
could be used in the second aim of the study. Two patients
who completed the 3-month follow-up did not receive a
closeout sonographic examination of the heel. The mean age
and BMI of the population ± SD were 49 ± 12 years (range,
25–75 years) and 32 ± 7.2 kg/m2 (range, 19.5–60.8 kg/m2),
respectively. The mean duration of heel pain and self-
reported standing time during a typical day were 5.6 ± 3.2
months and 3.3 ± 3.1 hours, respectively. The mean base-
line score for morning pain was 6.8 ± 2.2 (range, 2–10), and
the mean baseline score for afternoon pain was 5.9 ± 2.4
(range, 1.5–10). Twenty-six patients had bilateral heel pain,
and 44 presented with unilateral symptoms. There were no
differences in compliance among favorable and unfavor-
able groups for shoe gear/insole use, icing, or stretching
(all P > .05). Furthermore, the pain response was not asso-
ciated with the type of foot support (P > .05).
Aim 1: Are Demographic or Sonographic Findings 
Associated With the Magnitude of Heel Pain or Disability?
Biconvexity of the fascia, perifascial fluid, and edema within
the heel pad were not associated with quality of life, level of
disability, or self-reported pain (all P > .05). Similarly, the
absolute plantar fascia thickness at the infracalcaneal origin
and relative thickness at the origin compared to the con-
tralateral foot showed no association with pain magnitude
or amount of disability (P > .05). However, in patients pre-
senting with unilateral symptoms, the ratio of plantar fascia
thickness at a point 1 cm distal to the origin in the sympto-
matic heel compared to the same measurement from the
patient’s contralateral asymptomatic heel showed a mod-
erate positive association with pain magnitude according to
the total score (r = 0.309; P = .041; n = 44). In other words,
thicker fascia measurements taken at a point slightly distal
to the origin were associated with higher self-reported pain
scores on average.
Age showed a moderate negative association with
mean pain (r = –0.251; P = .036). Body mass index
showed a moderate positive association with both mean pain
(r = 0.278; P = .020) and disability determined by FFI-
R (r = 0.324; P = .006). Laterality of symptoms (right ver-
sus left), the duration of symptoms, and the self-reported
standing time were not associated with the magnitude of
pain or disability (all P > .05). However, patients of His-
panic ethnicity (n = 11) tended to report higher pain lev-
els on average compared to non-Hispanic patients (mean
score, 7.9 versus 6.0, respectively; P = .001).
Age also showed a weak positive trend with plantar fas-
cia thickness in the symptomatic heel (r = 0.218; P = .06).
However, sonographic characteristics of the plantar fascia
were not found to correlate with the BMI, duration of
symptoms, or mean standing time (hours) during the day
(all P > .05).
Aim 2: Are Demographic or Sonographic Characteristics
Predictive of the Treatment Response?
The demographics, pain and disability scores, and sono-
graphic characteristics of the study population at baseline
are provided in Table 1. Of the variables examined in the
univariate analysis, only biconvexity of the plantar fascia was
associated with an unfavorable response to mechanical
treatment of plantar fasciitis (univariate odds ratio, 4.3
[95% confidence interval, 1.08–16.9]; P = .038). Other
potentially important variables that were tested in the multi-
variate analysis included Hispanic ethnicity (Fisher exact
P = .096), laterality of symptoms (P = .198), use of a sham
insole (P = .167), and use of a prefabricated insole (P = .202).
The only significant predictor of an unfavorable treatment
response in the final multivariable analysis was biconvexity
of the plantar fascia (Table 2). 
Discussion 
The primary finding of this study was that sonographic
characteristics, namely the appearance of biconvexity,
helped identify those who were likely (and unlikely) to
report pain relief with a supportive treatment regimen for
proximal plantar fasciitis. The sonographic feature of bicon-
vexity was originally described by Akfirat et al6 using a case-
control study design. In their work, the authors included
patients with symptomatic heels and control participants
without plantar heel pain and found that increased bicon-
vexity of the plantar fascia was evident in most patients with
plantar fasciitis (19 of 21), whereas it was present in only
1 control participant (1 of 30). The authors concluded that
the finding of biconvexity is suggestive of plantar fasciitis
when it is present. Our work has now expanded on this
original observation and suggests that when biconvexity is
present, there may be a poorer prognosis for achieving pain
relief with supportive tier 1 therapies in patients with plan-
tar heel pain.
One widely referenced treatment algorithm for plan-
tar fasciitis, endorsed by the American College of Foot and
Ankle Surgeons, places stretching, shoe gear recommen-
dations, icing, and insoles in the “initial tier” and suggests
that these modalities should be used for 6 weeks before
progressing onto tier 2 modalities (eg, prescription physical
Fleischer et al—Prognostic Value of Diagnostic Sonography in Plantar Fasciitis
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therapy and a greater emphasis on corticosteroid injection
therapy).12 The algorithm further suggest that noninvasive
extracorporeal shock wave therapy, a tier 3 therapy, is not
typically performed earlier than 6 months into treatment.12
This treatment philosophy involves grouping patients by
general condition while gradually, and in some ways blindly,
working one’s way up the treatment ladder until arriving at
the desired therapeutic response. However, as the health care
environment in the United States continues to move away
from procedurally based payments for physician services and
more toward outcomes-based reimbursement arrange-
ments, it will be increasingly more important to tailor treat-
ment programs to individual patients. In this way, it may
helpful to begin risk stratifying patients early, perhaps even
during the initial visit, to better identify who is likely to
respond and who is not by using standard protocols so that
we can better provide the “proper measure” of therapy for
our patients right from the start. Based on the results of our
study, it is possible that patients with biconvexity may be
best served with corticosteroid injections and advanced
therapies12,13 earlier in the course of care. However, future
work will be needed in this area to fully support or refute
the value of such an approach.
In this study, it was interesting to learn that plantar
fascia thickness at initial presentation was not helpful in pre-
dicting the treatment response (odds ratio, 0.74; P = .318),
but, rather, biconvexity alone was. Although it is unclear
what is causing biconvexity and rounding of the plantar
fascia, it likely represents more advanced fasciitis within
the heel. It is possible that patients with biconvexity have
sustained greater soft tissue injury in the form of microtear-
ing, and the resulting focal enlargement represents a greater
and perhaps less organized reparative tissue response. It is
unlikely, however, that biconvexity suggests a longer-
 standing or more chronic condition, as biconvexity was not
related to the duration of symptoms in this study. Further
Table 1. Baseline Characteristics of the Study Population Stratified by Treatment Response (n = 63)
Characteristic Favorable Response (n = 38) Unfavorable Response (n = 25) P
Demographics
Age, y 50.4 ± 11.1 49.6 ± 13.8 .780
Female 24/38 (63) 17/25 (68) .693
BMI, kg/m2 31.6 ± 6.3 32.2 ± 8.4 .743
Race/ethnicity 0.68/0.13/0.11/0.08 0.64/0.04/0.28/0.04 .493
Right study foot 15/38 (39) 14/25 (56) .198
Bilateral symptoms 13/38 (34) 11/25 (44) .434
Duration of heel pain, mo 5.3 ± 3.4 5.7 ± 2.7 .564
Standing time/d, h 3.1 ± 3.3 2.7 ± 1.9 .595
Mechanical support
Sham insole 9/38 (24) 10/25 (40) .167
Prefabricated insole 15/38 (39) 6/25 (24) .202
Custom orthotic 14/38 (37) 9/25 (36) .946
Pain/disability score
Morning pain 7.0 ± 2.2 6.3 ± 2.3 .224
Evening pain 5.8 ± 2.4 5.8 ± 2.4 .954
FFI-R pain subscale 37.0  ± 9.3 34.3 ± 12.4 .327
FFI-R total 166 ± 45.8 164 ± 43.3 .863
SF-36 score 100 ± 5.6 99.3 ± 7.5 .619
Sonographic characteristics of fascia
Thickness at origin, mm 5.5 ± 1.1 5.1 ± 0.96 .163
Thickness at 1 cm, mm 3.8 ± 0.9 3.4 ± 0.94 .197
Thickness ratio 1 1.54 ± 0.38 1.58 ± 0.38 .764
Thickness at origin, opposite foot, mm 4.2 ± 1.0 4.1 ± 1.0 .715
Thickness ratio 2 1.35 ± 0.26 1.31 ± 0.30 .475
Biconvex shape 24/38 (63) 22/25 (88) .042
Perifascial fluid 6/38 (16) 2/25 (08) .461
Edema within heel pad 14/38 (37) 6/25 (24) .284
Values are displayed as mean ± SD or frequency (percentage of column total) where applicable; race/ethnicity is presented as percentage of
column total only for white/African American/Hispanic/other. A t test or Wilcoxon rank sum test was used for comparisons of continuous vari-
ables; a χ2 or Fisher exact test was used for comparisons of categorical variables. SF-36 indicates 36-item Short-Form Health Survey; thickness
ratio 1, thickness at origin in the study heel/thickness at 1 cm in the study heel; and thickness ratio 2, thickness at origin in the study heel/
thickness at origin in the nonstudy heel.
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research will be needed to provide a more sophisticated
answer to this question.
Another important finding in this study was that
plantar fascia thickness did not seem to correlate well
with the magnitude of symptoms or degree of disabil-
ity. Furthermore, changes in the self-reported pain level
over the 3-month study period were unrelated to
changes in plantar fascia thickness over this time (r =
0.056; P = .671; Figure 2). This observation is on the surface
quite contrary to what has been reported in the literature to
this point.14–21 Previous studies have shown a reduction in
plantar fascia thickness as patients responded positively
to treatment: anywhere from 14% improvement in
thickness over a 3-month period14 to as much as 60%
over as little as 1 week.18 However these studies all used
corticosteroid injections or extracorporeal shock wave
treatments, which likely explains the apparent disagree-
ment with our work, in which only supportive treatment
was used. The catabolic effects of local corticosteroid
injections could certainly account for the observed “thin-
ning” of the plantar fascia seen in previous studies. Based
on our findings, it appears that sonographic findings in
return patients who have received supportive therapy
alone should not weight heavily in clinical decisions such
as return to play.
In conclusion, our study indicates that patients with
biconvexity of the plantar fascia on sonography are less
likely to respond to supportive therapy than those without
this feature. Future studies may want to determine whether
patients with a biconvex plantar fascia on initial examina-
tion respond more favorably to a treatment approach that
uses earlier advancement onto tier 2 and 3 therapies.
Fleischer et al—Prognostic Value of Diagnostic Sonography in Plantar Fasciitis
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Table 2. Final Model for Predicting an Unfavorable Response to Mechanical Support (n = 63)
Risk Factora Regression Coefficient OR 95% CI P
Intercept –1.155 NA NA .500
Age –0.017 0.98 0.94–1.03 .453
BMI 0.012 1.01 0.94–1.09 .745
Plantar fascia biconvexity 1.561 4.76 1.16–19.5 .030
The area under the receiver operating characteristic curve for this model was 0.655 (Hosmer-Lemeshow goodness-of-fit test, 5.146; P = .742).
CI indicates confidence interval; NA, not applicable; and OR, odds ratio.
aObservations at baseline (patient’s initial presentation).
Figure 2.  Scatterplot showing the lack of association between change in plantar fascia thickness and change in heel pain symptoms during the
3-month follow-up (r = 0.056; P = .671; n = 61). Pain response (y-axis) refers to the change in self-reported pain at 3 months using the participant’s
average score for morning and evening pain. Positive values indicate an increasing level of pain, whereas negative values indicate a decreasing level
of pain. RMSE indicates root mean squared error; and USPFT, sonographic plantar fascia thickness.
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